-
Earnings Scheduled For February 7 (HUM, OMI, CTSH, HAS, CNA, SYY, IT, LO, BDX, PFG, L, PXD, GLUU, SNCR)
Monday, February 7, 2011 - 5:12am | 362Humana Inc (NYSE: HUM) is projected to report its Q4 earnings at $0.81 per share on revenue of $8.36 billion. Owens & Minor (NYSE: OMI) is projected to report its Q4 earnings at $0.51 per share on revenue of $2.06 billion. Cognizant Tech (NASDAQ: CTSH) is projected to post its Q4 earnings at $...
-
Feb 3, 2011 David Einhorn Speech
Sunday, February 6, 2011 - 8:08am | 245Is it just me or is he on some sort of publicity blitz. I thought we used to hear from him a couple of times a year, now he is on every business channel and speaking regularly. http://www.gurufocus.com/news.php?id=121395 Most interesting part to me was: Always buys protection in the form of puts...
-
Sirona Dental Systems Up 10.6% On Earnings Beat (SIRO)
Friday, February 4, 2011 - 4:29pm | 194Shares of Long Island City, New York-based Sirona Dental Systems, Inc. (Nasdaq: SIRO) are trading up 10.6% at $49.96 per share during the Friday afternoon trading session. The day's trading range for shares of Sirona Dental Systems, Inc has been between $49.11 and a 52-week high of $51.88 per share...
-
Medtronic: Expert Panel Publishes Findings on Underutilized Intrathecal Baclofen Therapy
Friday, February 4, 2011 - 3:26pm | 227A new scientific article has been published demonstrating the profound impact of spasticity on patients with multiple sclerosis and the benefits and underutilization of intrathecal baclofen therapy from Medtronic, Inc. (NYSE: MDT) as a treatment option for these patients. The paper, published this...
-
Calls Purchased on Hansen Medical (HNSN)
Friday, February 4, 2011 - 12:16pm | 118Shares of Hansen Medical (NASDAQ: HNSN) are lower on the session by 4.55%, currently trading at $2.10. The stock has been moving largely higher over the past two months and is currently trading above the 50-day and 200-day moving averages. Options traders are buying calls on the name today. A short...
-
Piper Jaffray Upgrades Cutera to Overweight (CUTR)
Friday, February 4, 2011 - 11:43am | 142Piper Jaffray is out with its report today on Cutera (NASDAQ: CUTR), upgrading CUTR from Underweight to Overweight. In a note to clients, Piper Jaffray writes, "We are raising our rating for CUTR from UW to OW based on an early positive read on a new product that we think can re-start sales...
-
Beckman Coulter Bidding War On CNBC (BEC)
Friday, February 4, 2011 - 11:35am | 51Beckman Coulter (NYSE: BEC) is rumored to be receiving several interested offers from outside parties. Currently the stock is 1.4% higher than yesterday's close and 2.3% higher than Wednesday's close on M&A excitement. Currently the Beckman Coulter takeover chatter is being discussed on CNBC.
-
Jefferies Analyzes Medical Technology & Hospital Supplies (SNN, SMA, WMGI)
Friday, February 4, 2011 - 11:11am | 231Piper Jaffray is out this morning with a research report on the Medical Technology and Hospital Supplies industry sectors, focusing on Smith & Nephew (NYSE: SNN), Symmetry Medical (NYSE: SMA), and Wright Medical Group (NASDAQ: WMGI). In the report, Piper Jaffray rated Smith & Nephew Neutral...
-
FDA Approves Hologic's Makena
Friday, February 4, 2011 - 10:12am | 80Hologic, Inc. (Nasdaq: HOLX) announced today the U.S. Food and Drug Administration (FDA) has approved Hologic's pharmaceutical named Makena, formerly known as Gestiva. Per the terms of an asset purchase agreement (the Agreement) between Hologic and KV Pharmaceutical Company, Hologic will transfer...
-
Piper Jaffray Upgrades Cutera To Overweight, PT To $12
Friday, February 4, 2011 - 9:42am | 28Piper Jaffray has upgraded Cutera, Inc. (NASDAQ: CUTR) from Underweight to Overweight and has raised the price target from $8 to $12.
-
Sirona Dental Reports Upbeat Q1 Earnings
Friday, February 4, 2011 - 7:54am | 57Sirona Dental Systems (NASDAQ: SIRO) reports its Q1 adjusted EPS at $0.96, beating the consensus of $0.81. SIRO reports its Q1 revenue at $235.6 million, versus the consensus of $227.69 million. SIRO shares gained 1.01% to close at $45.16 yesterday. Read more from Benzinga's Company news.
-
Mad Money Lightning Round OT: Cramer Thinks That It Is Time To Sell EW (CCG, IRDM, EW)
Thursday, February 3, 2011 - 9:33pm | 150Jim Cramer said on CNBC's Mad Money Lightning Round OT that Campus Crest Communities Inc (NYSE: CCG) is the real estate investment trust that basically provides students with the housing. He thinks that this business is a growth business, and he recommended it as a buy. Campus Crest Communities Inc...
-
Rewarding Quarter for Edwards - Analyst Blog
Thursday, February 3, 2011 - 4:51pm | 799Edwards Lifesciences Corporation (EW) has reported an EPS of 54 cents in the fourth quarter of fiscal 2010 compared to 40 cents in the year-ago period. However, after adjusting for certain items, the EPS came in at 55 cents, beating the Zacks Consensus Estimate by 3 cents and the year-ago quarter...
-
Rewarding Quarter for Edwards - Analyst Blog
Thursday, February 3, 2011 - 4:34pm | 799Edwards Lifesciences Corporation (EW) has reported an EPS of 54 cents in the fourth quarter of fiscal 2010 compared to 40 cents in the year-ago period. However, after adjusting for certain items, the EPS came in at 55 cents, beating the Zacks Consensus Estimate by 3 cents and the year-ago quarter...
-
Hospira Receives FDA Approval of Topotecan Injection
Thursday, February 3, 2011 - 1:02pm | 104Hospira, Inc. (NYSE: HSP) today announced U.S. Food and Drug Administration (FDA) approval of Topotecan Injection, the first solution formulation of the oncology drug approved in the United States. The medication is a generic version of Hycamtin, which had 2010 U.S. sales of more than $140 million...